Understanding ibogaine therapy candidate screening
If you are exploring ibogaine for addiction or mental health struggles, ibogaine therapy candidate screening is the first and most important step. This screening process is not a formality. It is how medical teams decide whether ibogaine can be offered to you with acceptable risk, or whether it could be dangerous to your heart, brain, or other organs.
Screening reveals far more than a simple yes or no. It clarifies your current health status, highlights any conditions that might need treatment first, and often uncovers safer or more suitable options for you. When you understand how screening works, you can approach ibogaine treatment with more realistic expectations and better questions for any provider you contact.
You can also use candidate screening criteria to pre-assess yourself before you apply. Resources such as ibogaine treatment eligibility requirements and who qualifies for ibogaine therapy can help you start that process.
What ibogaine screening is designed to protect you from
Ibogaine is a powerful psychoactive substance that affects many systems in your body at once. It can interrupt withdrawal and cravings, but it can also disturb your heart rhythm and nervous system if you have underlying conditions or conflicting medications.
In a 2022 study of people with opioid use disorder who received ibogaine in a monitored hospital setting, half of the patients temporarily reached a QTc heart rhythm measurement above 500 milliseconds, which is associated with higher cardiac risk. The average QTc increase was about 95 milliseconds, and although it reversed, it was clinically significant and required close monitoring [1]. That level of risk is why screening is so strict.
Candidate screening is designed to:
- Identify heart, liver, kidney, or neurological problems that could turn ibogaine from risky into life threatening
- Detect medications and substances that interact with ibogaine in dangerous ways
- Assess psychiatric history to reduce the risk of severe psychological reactions
- Confirm that you understand ibogaine is experimental and not a guaranteed cure
You will see these themes repeated across guidance from the Global Ibogaine Therapy Alliance, major clinics, and research programs [2].
How the ibogaine screening process usually works
Different clinics vary in style and setting, but most structured ibogaine therapy candidate screening follows a similar three stage pattern.
1. Pre application and information gathering
This is where you share your story and your health background. Typically you can expect:
- A detailed intake questionnaire covering medical history, substance use, mental health diagnoses, and current medications
- Discussion of why you want ibogaine and what you expect from it
- Initial review against published exclusion criteria such as serious heart disease, pregnancy, or unstable psychiatric conditions [2]
Clinics that follow best practices, such as Bassé Clinic and Avante Institute, review your history and current medications before even confirming dates, in order to rule out clear contraindications early [3].
2. Formal medical and psychological evaluation
If you pass the initial screen, you will be asked to complete a set of tests within a specific time window before treatment. These usually include:
- 12 lead ECG to measure your QT interval and overall heart rhythm
- Comprehensive blood work for electrolytes, liver function and kidney function
- Additional heart imaging or stress tests if you are older or have risk factors
- Psychiatric assessment and depression or anxiety inventories
For example, some programs require:
- A 12 lead ECG, and may disqualify you if your QT interval is over 430 ms for men or 450 ms for women, because this raises the risk of dangerous arrhythmias such as Torsades de Pointes [4]
- Full metabolic panels to check potassium and magnesium levels, liver enzymes (AST, ALT), and kidney markers (BUN, creatinine) so your body can safely metabolize ibogaine [4]
- Echocardiograms for anyone with a history or family history of heart disease, or for patients over certain age thresholds, in order to detect structural problems that a standard ECG might miss [5]
Psychological evaluation looks at diagnoses such as psychosis, bipolar I disorder, severe depression requiring certain medications, or seizure related conditions that can make ibogaine unsafe [6].
You can find a more structured overview of these requirements in medical requirements for ibogaine therapy and ibogaine therapy health requirements.
3. On site recheck and final clearance
On arrival at a reputable clinic, screening does not stop. You should expect:
- Repeat ECG and vital sign checks
- Updated blood tests if earlier labs are old or borderline
- Urine toxicology to confirm you have stopped contraindicated substances
- Review of informed consent documents and final interview about your expectations
Clinics like Bassé Clinic repeat ECGs on treatment day, adjust your electrolytes and fluids, and keep continuous cardiac monitoring during sessions because of the known QT effects of ibogaine [7]. If any results are unsafe, treatment is postponed or cancelled.
Medical conditions that disqualify you from ibogaine
Eligibility for ibogaine is not only about addiction severity or motivation. It is heavily shaped by your medical history. Ibogaine stresses your heart, liver, and nervous system, so providers are conservative in excluding risk.
Based on clinical guidelines and program criteria, you are very likely to be excluded if you have:
- Significant heart disease such as arrhythmias, heart failure, prior serious heart attack, or prolonged QT interval on ECG [8]
- Major respiratory conditions or recent pulmonary embolism
- Severe or chronic gastrointestinal disease, including certain major surgeries or active inflammatory conditions such as Crohn’s disease [9]
- Severe liver or kidney impairment, or active liver infections such as uncontrolled hepatitis or HIV, which interfere with drug metabolism [10]
- Uncontrolled high blood pressure or other unstable cardiovascular risk factors such as frequent chest pain or unexplained fainting [2]
- Severe endocrine or metabolic instability such as poorly controlled diabetes or thyroid disease [11]
Pregnancy is considered an absolute contraindication. Ibogaine can affect heart rhythm and fetal development, so all women of childbearing age are usually tested, and a positive pregnancy test means treatment is deferred until after pregnancy and recovery [12].
If you want to see how these medical factors fit into the bigger picture, who is eligible for ibogaine detox offers a broader overview.
Psychiatric and neurological exclusions
Your psychological history is equally important in ibogaine therapy candidate screening. Ibogaine produces intense, often visionary states and can temporarily disturb coordination and perception. This makes some conditions too risky.
Programs and guidelines commonly exclude people with:
- Psychotic spectrum disorders such as schizophrenia or schizoaffective disorder
- Bipolar I disorder, or a history of severe manic episodes
- History of psychotic episodes triggered by substances or stress
- Epilepsy or history of seizures, due to increased seizure risk under ibogaine [13]
- Severe dementia or degenerative neurological conditions that require medications which may interact with ibogaine [14]
In the Dutch hospital study, every ibogaine patient developed marked but temporary ataxia, which means severe unsteadiness and difficulty coordinating movement, peaking a few hours after dosing and resolving within 1 to 2 days [1]. This effect is manageable in otherwise healthy people under supervision, but much more dangerous in those with pre existing neurological conditions.
Milder psychomimetic effects such as wakeful dreaming, visual imagery, and brief disorientation were also observed, but in that study they stayed below the threshold for delirium and were generally well tolerated [1].
If you have a mental health diagnosis and are wondering whether ibogaine is realistic for you, it can help to read who should consider ibogaine therapy before speaking with a provider.
Medication interactions and substance use restrictions
Many people exploring ibogaine are taking prescribed medications, using substitution therapies, or drinking and using other substances. From a safety standpoint, this is one of the most complex parts of ibogaine therapy candidate screening.
Medications that may disqualify you or require long tapers
Ibogaine is metabolized by CYP2D6 liver enzymes and can prolong the QT interval on your ECG. That means any drug that:
- Prolongs your QT interval, or
- Shares the same liver metabolism pathway, or
- Increases serotonin to a high degree
can interact dangerously with ibogaine.
Programs and guidelines highlight high risk categories such as:
- Certain antidepressants, especially SSRIs, SNRIs, and MAOIs
- Antipsychotics and many antiepileptic drugs
- Anti arrhythmic medications
- Some beta blockers and centrally acting sedatives such as benzodiazepines
- Drugs or foods that inhibit CYP2D6, for example paroxetine and grapefruit products [15]
You are not expected to stop psychiatric medications on your own. In fact, stopping some of them suddenly can be dangerous. If you are taking any of these, an ethical clinic will usually require coordination with your prescribing doctor and may conclude that ibogaine is not safe for you.
Required abstinence from alcohol and other substances
Ibogaine is almost never given to someone who is still actively drinking heavily or using certain drugs. Standard screening procedures include:
- Urine toxicology screening to verify that long acting opioids such as methadone or buprenorphine, as well as benzodiazepines, have been stopped for a specific number of days or weeks. Some programs require at least 7 to 14 days off methadone before ibogaine because of interaction and withdrawal risk [16]
- A medically supervised detox period from alcohol, often at least 12 days, to allow your liver to recover and to prevent dangerous withdrawal overlapping with ibogaine effects [11]
- Strict avoidance of stimulants, including cocaine, amphetamines, and often even caffeine, leading up to treatment because of their cardiovascular impact [11]
If you cannot safely stop certain medications or substances, ibogaine may not be appropriate. In those cases, you might be better served by other evidence based addiction treatments. Articles such as who can receive ibogaine therapy and ibogaine treatment patient requirements can help you compare your current situation with typical program expectations.
Cardiac testing and why it matters so much
Cardiac safety is the central focus of ibogaine therapy candidate screening. Even if you feel healthy, certain heart rhythm characteristics make ibogaine riskier for you.
Guidelines from the Global Ibogaine Therapy Alliance and real world programs recommend:
- Mandatory 12 lead ECG for every candidate to check baseline QT, heart rate, and rhythm
- Additional tests such as stress echocardiograms or 24 hour Holter monitoring if you are over 45 or have risk factors like hypertension, diabetes, nicotine use, or high cholesterol [17]
- Exclusion or cardiologist review if you have symptoms such as chest pain, shortness of breath, frequent indigestion that may actually be cardiac, or unexplained fainting [2]
In the Netherlands hospital study, patients were converted from methadone to morphine for 8 days before ibogaine because methadone itself can prolong QT. They then monitored heart rhythm, blood pressure, and ibogaine related ataxia and psychological effects for at least 24 hours after dosing [1]. This gives you a sense of the level of caution that is appropriate.
A quick summary of typical cardiac screening elements is below.
| Screening element | What it looks for | Why it matters with ibogaine |
|---|---|---|
| 12 lead ECG | QT interval, arrhythmias, conduction delays | Ibogaine can further prolong QT and trigger dangerous rhythms |
| Echocardiogram | Structural heart disease, valve problems | Structural issues may decompensate under stress |
| Stress test or Holter monitor | Exercise induced or intermittent arrhythmias | Some rhythm issues appear only under stress |
| Blood pressure checks | Hypertension or hypotension | Both extremes raise risk of cardiac events |
If a clinic does not require at least a standard ECG and baseline labs, you should treat that as a red flag and consider looking elsewhere. You can compare different centers’ safety practices with the help of ibogaine treatment screening criteria.
Informed consent and your readiness for ibogaine
Even if you clear all medical and psychiatric hurdles, your attitude and expectations still matter. Many programs list informed voluntary consent as the primary inclusion criterion.
Guidelines emphasize that you should:
- Be seeking ibogaine of your own free will, not coerced by family, courts, or partners
- Understand that ibogaine is experimental and not approved by the US FDA for addiction or mental health treatment
- Recognize that ibogaine is not a magic bullet and that integration, therapy, and continued support are needed afterward [18]
Clinics such as Bassé and Tabula Rasa provide detailed informed consent forms before or upon arrival and review them with you to make sure you truly understand benefits, risks, and alternatives [19]. Avante Institute also uses structured consent and psychological questionnaires to assess your readiness [14].
If you find yourself hoping ibogaine will instantly fix everything without follow up work, that is a sign to slow down and seek more education and support before moving forward.
What screening reveals about your suitability
By the time you finish ibogaine therapy candidate screening, you will know far more about your own health than when you started. Regardless of whether you are cleared, screening tends to reveal:
- How your heart, liver, kidneys, and nervous system are functioning right now
- Which medications or substances are posing hidden risks to your safety
- Whether your psychiatric and neurological history aligns with safe ibogaine use
- How motivated you are and whether your expectations are realistic
If you are accepted, you are likely to fit a pattern seen in many clinical programs:
- You have medically stable heart, liver, and kidney function
- You do not have severe psychotic or seizure related conditions
- You are able to pause or discontinue interacting medications under medical supervision
- You have undergone appropriate detox or substitution adjustments leading up to treatment
- You consent voluntarily and are prepared to engage in aftercare and integration work
If you are not accepted, that does not mean you have failed. It means ibogaine is not the safest tool for your current situation. In many cases, you can use what the screening revealed to pursue more appropriate treatments, stabilize key conditions, and revisit ibogaine later, or decide that other evidence based options are a better long term fit.
To continue evaluating your options, you may find it helpful to read ibogaine therapy health requirements and ibogaine treatment eligibility requirements, then bring your questions to a qualified medical professional who understands both addiction medicine and ibogaine specific risks.
References
- (Addiction)
- (Global Ibogaine Therapy Alliance)
- (Basse Ibogaine, Avante Ibogaine)
- (New Roots Ibogaine)
- (Avante Ibogaine, New Roots Ibogaine)
- (PMC)
- (Basse Ibogaine)
- (Global Ibogaine Therapy Alliance, PMC)
- (Global Ibogaine Therapy Alliance, Avante Ibogaine)
- (Experience Ibogaine, Avante Ibogaine)
- (Experience Ibogaine)
- (Experience Ibogaine, New Roots Ibogaine)
- (Experience Ibogaine, PMC)
- (Avante Ibogaine)
- (Experience Ibogaine, Global Ibogaine Therapy Alliance)
- (New Roots Ibogaine, PMC)
- (Global Ibogaine Therapy Alliance, New Roots Ibogaine)
- (Global Ibogaine Therapy Alliance, Tabula Rasa Retreat)
- (Basse Ibogaine, Tabula Rasa Retreat)






















